-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Cero Therapeutics Holdings, Inc. quarterly Depreciation history and growth rate for 2023.
- Cero Therapeutics Holdings, Inc. Depreciation for the quarter ending February 13, 2024 was $37.4 K.